14 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
nominees, our Board of Directors will consist of six members, five of whom satisfy the independence requirements of the Nasdaq Listing Rules.
We believe
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
the independence requirements of the Nasdaq Listing Rules.
Our Nominating Committee reviewed the qualifications and suitability of each of the director nominees
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
behalf or in right of it or the Company or any shareholders, employees or creditors of Company.
SECTION 18. Research Analyst Independence. The Company
20-F/A
t0g0h1 2b0fx
23 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F
3lrllr6bj ku
31 Mar 15
Annual report (foreign)
12:00am
424B4
a6ugq
31 Jul 14
Prospectus supplement with pricing info
12:00am
F-1/A
fxp 4vrgl
8 Jul 14
Registration statement (foreign) (amended)
12:00am
- Prev
- 1
- Next